Article by Groshan Fabiola
Leukemia has two key varieties: acute and chronic. In what concerns acute leukemia, there are two forms: if leukemia entails lymphocytes, we are dealing with acute lymphoblastic leukemia, and if it entails myeloid cells, is referred to as acute myelogenous leukemia. Depending on the particular cell that has turn into malignant, there can be several various sorts of acute lymphoblastic leukemia and acute myelogenous leukemia.It was seen that chronic leukemia affects primarily the myeloid cells in the bone marrow. This is called chronic myelogenous leukemia, and is found mostly in adults, but kids and teenagers can develop it too.We should mention that there exists a disorder of the bone marrow identified as myelodysplastic syndrome. Typically referred to as a pre-leukemia syndrome since patients with it have a significantly increased risk of creating leukemia, this syndrome is usually linked with low blood cell counts and increased requirements for transfusions.
Allogeneic bone marrow stem cell transplantation is used to treat a variety of childhood leukemias or cancers and myelodysplastic syndrome that involve the cells inside the bone marrow. In this transplant, there are employed one more person's bone marrow cells to restore bone marrow right after high dose chemotherapy and radiation therapy.As an benefit of an allogeneic transplant over an autologous transplant we can mention the "graft-versus-leukemia effect". The donor's healthy bone marrow kills residual leukemia cells, and in this way decreases the patient's opportunity of relapse.As a disadvantage of an allogeneic bone marrow stem cell transplant we can mention the risk of graft-versus-host disease. This happens when the other person's bone marrow attacks the recipient's body. In this way, there appears a disease that affects the skin, liver and numerous other organs. In this case, therapy with immunosuppressive drugs is needed.
When a matched donor is obtainable, there can be performed transplantation for high-risk leukemia patients in first remission. In quite high-risk patients, like those with leukemia who fail to obtain 1st remission with chemotherapy, there can be carried out an unrelated donor transplant as soon as remission is achieved. As eligible we can mention infants with leukemia, youngsters with high-risk lymphoblastic leukemia and young children with acute myelogenous leukemia. Also, young children with myelodysplastic syndrome are eligible for transplant as soon as the diagnosis is established.
Many young children with acute leukemias whose leukemia has relapsed can have bone marrow stem cell transplantation. Transplantation can be from related donors like brothers, sisters, parents, and occasionally more distant relatives such as cousins and grandparents.Also, transplantation can be from matched unrelated donors, such as umbilical cord blood.In what concerns youngsters with chronic myelogenous leukemia who can't be put into total remission with drugs, they really should undergo a transplant as early as probable in the course of the disease.
About the Author
For much more resources on different leukemia related issues like leukemia symptoms, leukemia causes and a lot of more go to http://www.leukemia-guide.com.
This patient education video explains MDS. It initial discusses its symptoms and causes and how it is diagnosed and treated. It also includes ideas for coping with MDS.
0 comments:
Post a Comment